These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38645931)

  • 21. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
    Francia V; Schiffelers RM; Cullis PR; Witzigmann D
    Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracing the
    Mohammad-Beigi H; Scavenius C; Jensen PB; Kjaer-Sorensen K; Oxvig C; Boesen T; Enghild JJ; Sutherland DS; Hayashi Y
    ACS Nano; 2020 Aug; 14(8):10666-10679. PubMed ID: 32806026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of Biomolecular Corona for Molecular Imaging.
    Mahmoudi M; Moore A
    Mol Imaging Biol; 2021 Feb; 23(1):1-10. PubMed ID: 33095421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced Light Source Analytical Techniques for Exploring the Biological Behavior and Fate of Nanomedicines.
    Cao M; Zhang K; Zhang S; Wang Y; Chen C
    ACS Cent Sci; 2022 Aug; 8(8):1063-1080. PubMed ID: 36032763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Particle-by-Particle In Situ Characterization of the Protein Corona via Real-Time 3D Single-Particle-Tracking Spectroscopy*.
    Tan X; Welsher K
    Angew Chem Int Ed Engl; 2021 Oct; 60(41):22359-22367. PubMed ID: 34015174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona.
    Tang H; Zhang Y; Yang T; Wang C; Zhu Y; Qiu L; Liu J; Song Y; Zhou L; Zhang J; Wong YK; Liu Y; Xu C; Wang H; Wang J
    Nat Nanotechnol; 2023 Sep; 18(9):1067-1077. PubMed ID: 37537273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery.
    Saiding Q; Zhang Z; Chen S; Xiao F; Chen Y; Li Y; Zhen X; Khan MM; Chen W; Koo S; Kong N; Tao W
    Adv Drug Deliv Rev; 2023 Dec; 203():115116. PubMed ID: 37871748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
    Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harnessing Protein Corona for Biomimetic Nanomedicine Design.
    Chen Z; Chen X; Huang J; Wang J; Wang Z
    Biomimetics (Basel); 2022 Sep; 7(3):. PubMed ID: 36134930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pay Attention to Biological Nanoparticles when Studying the Protein Corona on Nanomedicines.
    Simonsen JB; Münter R
    Angew Chem Int Ed Engl; 2020 Jul; 59(31):12584-12588. PubMed ID: 32347625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Label-free in-flow detection of receptor recognition motifs on the biomolecular corona of nanoparticles.
    Gianneli M; Polo E; Lopez H; Castagnola V; Aastrup T; Dawson KA
    Nanoscale; 2018 Mar; 10(12):5474-5481. PubMed ID: 29511756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biomolecular gastrointestinal corona in oral drug delivery.
    Aljabbari A; Kihara S; Rades T; Boyd BJ
    J Control Release; 2023 Nov; 363():536-549. PubMed ID: 37776905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microfluidic Examination of the "Hard" Biomolecular Corona Formed on Engineered Particles in Different Biological Milieu.
    Weiss ACG; Kempe K; Förster S; Caruso F
    Biomacromolecules; 2018 Jul; 19(7):2580-2594. PubMed ID: 29668268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine.
    Fasoli E
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1139-1152. PubMed ID: 33007792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Protein Corona in Nanoflare-Based Biomolecular Detection and Quantification.
    Wang H; Dardir K; Lee KB; Fabris L
    Bioconjug Chem; 2019 Oct; 30(10):2555-2562. PubMed ID: 31479244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.
    Arcella A; Palchetti S; Digiacomo L; Pozzi D; Capriotti AL; Frati L; Oliva MA; Tsaouli G; Rota R; Screpanti I; Mahmoudi M; Caracciolo G
    ACS Chem Neurosci; 2018 Dec; 9(12):3166-3174. PubMed ID: 30015470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomolecular Corona of Gold Nanoparticles: The Urgent Need for Strong Roots to Grow Strong Branches.
    Boselli L; Castagnola V; Armirotti A; Benfenati F; Pompa PP
    Small; 2024 Apr; 20(15):e2306474. PubMed ID: 38085683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.